We are live on ! Find out more
SCM

Sio Capital Management Portfolio holdings

AUM $697M
1-Year Est. Return 79.73%
This Fund
S&P 500
This Quarter Est. Return
-10.56%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$273M
AUM Growth
+$47.4M
Cap. Flow
+$74.9M
Cap. Flow %
27.41%
Top 10 Hldgs %
53.37%
Holding
60
New
18
Increased
13
Reduced
8
Closed
18

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$11.5M
2
CAH icon
Cardinal Health
CAH
+$10.9M
3
LLY icon
Eli Lilly
LLY
+$10.6M
4
SHPG
Shire pic
SHPG
+$10.6M
5
AGN
Allergan plc
AGN
+$10.3M

Top Sells

Rank Stock Value
1
DYAX
DYAX CORPORATION
DYAX
+$25.9M
2
CI icon
Cigna
CI
+$7.15M
3
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
+$6.51M
4
SNY icon
Sanofi
SNY
+$6.32M
5
ABBV icon
AbbVie
ABBV
+$6.15M

Sector Composition

Rank Sector Weight
1 Healthcare 73.73%
2 Industrials 1.65%
3 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LDRH
26
DELISTED
LDR HOLDINGS CORP COM STK
LDRH
$3.67M 1.34%
+144,033
New +$3.01M
ASND icon
27
Ascendis Pharma A/S
ASND
$16.5B
$3.47M 1.27%
187,220
-97,565
-34% -$1.73M
RAD
28
DELISTED
Rite Aid Corporation
RAD
$3.36M 1.23%
20,639
+12,033
+140% +$1.9M
RIGL icon
29
Rigel Pharmaceuticals
RIGL
$723M
$3.36M 1.23%
+161,690
New +$3.99M
CPXX
30
DELISTED
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
$2.69M 0.98%
+243,475
New +$798K
SGMO
31
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$2.39M 0.88%
+395,496
New +$2.37M
MTEM
32
DELISTED
Molecular Templates, Inc.
MTEM
$1.82M 0.67%
23,953
-314
-1% -$18.5K
ATHN
33
PUT
DELISTED
Athenahealth, Inc.
ATHN
$1.39M 0.51%
+10,000
New +$1.37M
SCYX icon
34
SCYNEXIS
SCYX
$37.4M
$1.15M 0.42%
3,557
+1,530
+75% +$579K
AGRX
35
DELISTED
Agile Therapeutics
AGRX
$1.03M 0.38%
83
+46
+124% +$594K
LNTH icon
36
Lantheus
LNTH
$6.51B
$843K 0.31%
446,098
+82,350
+23% +$182K
SRPT icon
37
PUT
Sarepta Therapeutics
SRPT
$1.64B
$566K 0.21%
29,000
-21,000
-42% -$367K
OASM
38
DELISTED
Oasmia Pharmaceutical AB
OASM
$523K 0.19%
123,000
– –
ADMS
39
DELISTED
Adamas Pharmaceuticals
ADMS
$289K 0.11%
20,000
-97,257
-83% -$1.64M
EDIT icon
40
Editas Medicine
EDIT
$399M
$266K 0.1%
+7,714
New +$203K
IMNP
41
DELISTED
Immune Pharmaceuticals Inc.
IMNP
$85K 0.03%
9,883
– –
NSPR icon
42
InspireMD
NSPR
$31.4M
– –
0
– –
ABBV icon
43
AbbVie
ABBV
$465B
– –
-103,809
Closed -$6.15M
ADUS icon
44
Addus HomeCare
ADUS
$2.22B
– –
-125,526
Closed -$2.92M
AVDL
45
DELISTED
Avadel Pharmaceuticals
AVDL
– –
-124,017
Closed -$1.51M
BMY icon
46
Bristol-Myers Squibb
BMY
$129B
– –
-53,862
Closed -$3.71M
CI icon
47
Cigna
CI
$78.4B
– –
-48,855
Closed -$7.15M
HRTX icon
48
Heron Therapeutics
HRTX
$93.4M
– –
-99,772
Closed -$2.66M
MDT icon
49
Medtronic
MDT
$112B
– –
-35,000
Closed -$2.69M
MRK icon
50
Merck
MRK
$322B
– –
-56,985
Closed -$2.87M
1
2
3

Similar funds

GUB
Golden Unicorn BVI Road Town $697M AUM 55.92% 1-Year Est. Return
KLI
Kelman-Lazarov Inc Memphis, Tennessee $698M AUM 14.07% 1-Year Est. Return
JA
JLB & Associates Plymouth, Michigan $696M AUM 17.86% 1-Year Est. Return
WIC
Wilkins Investment Counsel Boston, Massachusetts $698M AUM 17.36% 1-Year Est. Return
AAM
Auxier Asset Management Aurora, Oregon $696M AUM 18.07% 1-Year Est. Return
TCM
Tensile Capital Management Larkspur, California $698M AUM 2.4% 1-Year Est. Return
CA
Calton & Associates Tampa, Florida $696M AUM 18.3% 1-Year Est. Return
SAM
Silverback Asset Management Chapel Hill, North Carolina $699M AUM 72.42% 1-Year Est. Return

Sio Capital Management's Q1 2016 Portfolio in Review

As of Q1 2016, Sio Capital Management held 60 positions worth $273M, up 21% from $226M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Sio Capital Management deployed $74.9M of net new capital in Q1 2016, opening 18 new positions and adding to 13 existing holdings. Its largest new stake was Amgen: 77,721 shares worth $11.7M.

By sector, the portfolio is most concentrated in Healthcare at 74% of assets, down from 78% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Sanofi, an estimated $6.32M trimmed.

  • Sio Capital Management's largest Q1 2016 buy was Amgen: 77,721 shares worth $11.7M.
  • Sio Capital Management added most to Quotient Limited Ordinary Shares in Q1 2016, an estimated $5.96M increase.
  • Sio Capital Management's biggest Q1 2016 reduction was Sanofi, cutting an estimated $6.32M.
  • Sio Capital Management fully exited DYAX CORPORATION in Q1 2016, selling an estimated $25.9M.
  • Sio Capital Management's ten largest holdings make up 53% of its $273M portfolio in Q1 2016.
  • Sio Capital Management opened 18 new positions and closed 18 in Q1 2016.
  • Sio Capital Management's portfolio value rose 21% quarter-over-quarter to $273M.

Based on Sio Capital Management's 13F filing for Q1 2016, filed 16 May 2016.